Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
about
Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisInterleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 productionIL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino SinusitisImportant Role of the IL-32 Inflammatory Network in the Host Response against Viral InfectionOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsInterleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices.Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alphaIntracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice.The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritisInterleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.Novel insights into the biology of interleukin-32.Osteoimmunology in orthodontic tooth movement.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome.A review on interleukins: The key manipulators in rheumatoid arthritis.Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.Determination of the differentiation capacities of murines' primary mononucleated cells and MC3T3-E1 cellsIL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models.IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis.Role of interleukin-32 in cancer biology.Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis.Interleukin-32: its role in asthma and potential as a therapeutic agent.Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric CancerThe Biology and Role of Interleukin-32 in Tuberculosis
P2860
Q24311417-7368919F-BA84-482F-A7C8-A168C7516345Q24317887-FE88E114-7CA8-435F-A8F9-9C6878153A06Q26753017-AE30E861-1CF3-48C2-96E0-E0DB2E84AD27Q26826958-97291E4E-8DDF-4D07-9397-194DE211B52CQ26828486-9DFBF8CB-90DB-4B4D-99BE-2D1941CFC1BAQ30411120-069160D4-3B40-4056-86C6-EAB98DDD3324Q33758838-E0D0A587-79A1-4342-9832-C2B86ADF9A8AQ33822541-C62B2059-D740-479B-9776-8DBD2E5FD644Q35552026-86BDDDE2-6988-4314-A323-E026D4634D22Q36246023-41D11CD5-7462-48DD-B02C-A404E8CA95E2Q36318831-4E2F95DD-DBC8-484F-AD8F-018713365ABEQ36629365-61D4892A-F579-45EB-BC98-52B92C80DD74Q36686444-58C500ED-480A-4AAE-961E-6F8FDE0F54A6Q36907602-1591F9A9-48A1-4452-A8C3-AA3CF87E89B6Q37581596-BF804179-D21E-4650-B3C3-B6393121318AQ38086768-2965108C-D42F-4882-A505-75067E862BF8Q38231572-6429B1E0-63EF-4963-A7B2-516C3862A925Q38334454-BA33E4F0-56F4-47A1-9439-39A9AB658EA9Q38743542-F1542441-8EBC-4AD4-BEC0-1F9F37138D98Q39029629-956E9FCE-986B-47FE-B5F4-3606B614933DQ41495034-2F5AA8D8-F40F-4272-A0F8-1965EA8E0D5FQ42357357-173AE556-8854-415E-A54C-E4321694E0ECQ44221482-F667A9A7-A400-45C5-BA69-08E050B07DB9Q49320015-3AEF9415-F4E0-4548-9A10-DCCC021ADDB8Q54372061-6134935E-C1BE-49C1-B593-7C56EFD10315Q55264916-D103B6C4-706A-427B-BBAB-46AC1BE633F1Q55435298-A90615E6-B5BF-40F7-B7AB-8E69E14793DAQ55479672-7DDDFBF5-5791-4855-B643-50FCC07B1294Q58584387-5C50058B-0A62-4925-8F00-7371B1C1ACCCQ58694023-FC5D08FB-4A82-4B51-BD2E-E5EBDEA0C849
P2860
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@ast
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en-gb
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@nl
type
label
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@ast
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en-gb
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@nl
altLabel
Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
@en
prefLabel
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@ast
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en-gb
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@nl
P2860
P3181
P1433
P1476
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
@en
P2093
Afsie Sabokbar
P2860
P3181
P356
10.1371/JOURNAL.PONE.0004173
P407
P577
2009-01-01T00:00:00Z